ArticleClinical cancer research : an official journal of the American Association for Cancer Research2008

Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.

Alejandro D Ricart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.